Nuclear medicine in the assessment and prevention of cancer therapy-related cardiotoxicity: prospects and proposal of use by the European Association of Nuclear Medicine (EANM)

Nuclear medicine in the assessment and prevention of cancer therapy-related cardiotoxicity : prospects and proposal of use by the European Association of Nuclear Medicine (EANM)

Correction to: European Journal of Nuclear Medicine and Molecular Imaginghttps://doi.org/10.1007/s00259-022-05991-7The authors regret that their names in the original article are incorrect as the first and last names were interchanged. It is now corrected in erratum article.
Cardiotoxicity may present as (pulmonary) hypertension, acute and chronic coronary syndromes, venous thromboembolism, cardiomyopathies/heart failure, arrhythmia, valvular heart disease, peripheral arterial disease, and myocarditis. Many of these disease entities can be diagnosed by established cardiovascular diagnostic pathways. Nuclear medicine, however, has proven promising in the diagnosis of cardiomyopathies/heart failure, and peri- and myocarditis as well as arterial inflammation. This article first outlines the spectrum of cardiotoxic cancer therapies and the potential side effects. This will be complemented by the definition of cardiotoxicity using non-nuclear cardiovascular imaging (echocardiography, CMR) and biomarkers. Available nuclear imaging techniques are then presented and specific suggestions are made for their application and potential role in the diagnosis of cardiotoxicity.

Ingår i:European Journal of Nuclear Medicine and Molecular Imaging: Springer Nature50:3, s. 792-8121619-70701619-7089

Av författaren/redakt...: Totzeck, Matthia ...; Aide, Nicolas; Bauersachs, Joha ...; Bucerius, Jan; Georgoulias, Pan ...; Herrmann, Ken; visa fler...; Hyafil, Fabien; Kunikowska, Jola ...; Lubberink, Mark; Nappi, Carmela; Rassaf, Tienush; Saraste, Antti; Sciagra, Roberto; Slart, Riemer H ...; Verberne, Hein; Rischpler, Chris ...; visa färre...

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.